nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—ABCB1—ulcerative colitis	0.273	1	CbGaD
Rilpivirine—SLCO1B1—Sulfasalazine—ulcerative colitis	0.0605	0.104	CbGbCtD
Rilpivirine—ABCG2—Sulfasalazine—ulcerative colitis	0.048	0.0822	CbGbCtD
Rilpivirine—CYP2B6—Nicotine—ulcerative colitis	0.0434	0.0744	CbGbCtD
Rilpivirine—CYP2B6—Cholecalciferol—ulcerative colitis	0.039	0.0667	CbGbCtD
Rilpivirine—ABCG2—Hydrocortisone—ulcerative colitis	0.0385	0.066	CbGbCtD
Rilpivirine—CYP3A4—Budesonide—ulcerative colitis	0.0307	0.0525	CbGbCtD
Rilpivirine—CYP2C19—Nicotine—ulcerative colitis	0.0276	0.0473	CbGbCtD
Rilpivirine—CYP1A2—Nicotine—ulcerative colitis	0.0255	0.0436	CbGbCtD
Rilpivirine—CYP2C19—Cholecalciferol—ulcerative colitis	0.0248	0.0424	CbGbCtD
Rilpivirine—ABCG2—Dexamethasone—ulcerative colitis	0.024	0.041	CbGbCtD
Rilpivirine—ABCB1—Methylprednisolone—ulcerative colitis	0.0229	0.0391	CbGbCtD
Rilpivirine—CYP2C19—Prednisone—ulcerative colitis	0.0172	0.0294	CbGbCtD
Rilpivirine—CYP2B6—Dexamethasone—ulcerative colitis	0.0169	0.0289	CbGbCtD
Rilpivirine—ABCB1—Betamethasone—ulcerative colitis	0.0149	0.0254	CbGbCtD
Rilpivirine—ABCB1—Prednisolone—ulcerative colitis	0.0147	0.0251	CbGbCtD
Rilpivirine—ABCB1—Hydrocortisone—ulcerative colitis	0.0139	0.0238	CbGbCtD
Rilpivirine—ABCB1—Prednisone—ulcerative colitis	0.0138	0.0237	CbGbCtD
Rilpivirine—CYP3A4—Methylprednisolone—ulcerative colitis	0.0137	0.0234	CbGbCtD
Rilpivirine—CYP3A4—Nicotine—ulcerative colitis	0.0133	0.0228	CbGbCtD
Rilpivirine—CYP3A4—Cholecalciferol—ulcerative colitis	0.012	0.0205	CbGbCtD
Rilpivirine—CYP2C19—Dexamethasone—ulcerative colitis	0.0107	0.0183	CbGbCtD
Rilpivirine—CYP3A4—Triamcinolone—ulcerative colitis	0.0104	0.0178	CbGbCtD
Rilpivirine—CYP3A4—Betamethasone—ulcerative colitis	0.0089	0.0152	CbGbCtD
Rilpivirine—CYP3A4—Prednisolone—ulcerative colitis	0.00878	0.015	CbGbCtD
Rilpivirine—ABCB1—Dexamethasone—ulcerative colitis	0.00864	0.0148	CbGbCtD
Rilpivirine—CYP3A4—Hydrocortisone—ulcerative colitis	0.00833	0.0143	CbGbCtD
Rilpivirine—CYP3A4—Prednisone—ulcerative colitis	0.0083	0.0142	CbGbCtD
Rilpivirine—CYP3A4—Dexamethasone—ulcerative colitis	0.00518	0.00887	CbGbCtD
Rilpivirine—Lipase increased—Mesalazine—ulcerative colitis	0.00263	0.0242	CcSEcCtD
Rilpivirine—Buffalo hump—Prednisone—ulcerative colitis	0.00204	0.0188	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors—NR5A2—ulcerative colitis	0.00198	0.0622	CbGpPWpGaD
Rilpivirine—Adrenal insufficiency—Prednisone—ulcerative colitis	0.00195	0.018	CcSEcCtD
Rilpivirine—Etravirine—ABCB1—ulcerative colitis	0.00195	0.697	CrCbGaD
Rilpivirine—Lipohypertrophy—Prednisone—ulcerative colitis	0.00187	0.0172	CcSEcCtD
Rilpivirine—Hepatotoxicity—Mercaptopurine—ulcerative colitis	0.00184	0.017	CcSEcCtD
Rilpivirine—Nephrotic syndrome—Mesalazine—ulcerative colitis	0.0016	0.0147	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptor transcription pathway—NR5A2—ulcerative colitis	0.00157	0.0491	CbGpPWpGaD
Rilpivirine—Opportunistic infection—Hydrocortisone—ulcerative colitis	0.00136	0.0126	CcSEcCtD
Rilpivirine—Abnormal dreams—Nicotine—ulcerative colitis	0.00136	0.0126	CcSEcCtD
Rilpivirine—Cholecystitis—Mesalazine—ulcerative colitis	0.00135	0.0124	CcSEcCtD
Rilpivirine—NR1I2—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.00132	0.0412	CbGpPWpGaD
Rilpivirine—NR1I2—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.00131	0.0412	CbGpPWpGaD
Rilpivirine—Platelet count decreased—Mesalazine—ulcerative colitis	0.0013	0.012	CcSEcCtD
Rilpivirine—Opportunistic infection—Methylprednisolone—ulcerative colitis	0.00128	0.0118	CcSEcCtD
Rilpivirine—Transaminases increased—Mesalazine—ulcerative colitis	0.00127	0.0117	CcSEcCtD
Rilpivirine—Cholelithiasis—Mesalazine—ulcerative colitis	0.00124	0.0114	CcSEcCtD
Rilpivirine—ABCG2—Abacavir transmembrane transport—ABCB1—ulcerative colitis	0.00122	0.0381	CbGpPWpGaD
Rilpivirine—Opportunistic infection—Betamethasone—ulcerative colitis	0.00117	0.0107	CcSEcCtD
Rilpivirine—Opportunistic infection—Dexamethasone—ulcerative colitis	0.00117	0.0107	CcSEcCtD
Rilpivirine—Sleep disorder—Nicotine—ulcerative colitis	0.00116	0.0107	CcSEcCtD
Rilpivirine—Depressed mood—Methylprednisolone—ulcerative colitis	0.00115	0.0106	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors—HNF4A—ulcerative colitis	0.00111	0.0347	CbGpPWpGaD
Rilpivirine—Hepatotoxicity—Azathioprine—ulcerative colitis	0.0011	0.0101	CcSEcCtD
Rilpivirine—Opportunistic infection—Prednisone—ulcerative colitis	0.00101	0.00935	CcSEcCtD
Rilpivirine—Hepatotoxicity—Mesalazine—ulcerative colitis	0.001	0.00922	CcSEcCtD
Rilpivirine—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000903	0.0283	CbGpPWpGaD
Rilpivirine—NR1I2—Nuclear Receptor transcription pathway—HNF4A—ulcerative colitis	0.000876	0.0274	CbGpPWpGaD
Rilpivirine—Pazopanib—ABCB1—ulcerative colitis	0.000848	0.303	CrCbGaD
Rilpivirine—Abdominal discomfort—Nicotine—ulcerative colitis	0.00083	0.00764	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Mesalazine—ulcerative colitis	0.000817	0.00752	CcSEcCtD
Rilpivirine—Sleep disorder—Budesonide—ulcerative colitis	0.000797	0.00734	CcSEcCtD
Rilpivirine—Abnormal dreams—Mesalazine—ulcerative colitis	0.000763	0.00703	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000757	0.0237	CbGpPWpGaD
Rilpivirine—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000755	0.0236	CbGpPWpGaD
Rilpivirine—Hepatobiliary disease—Mercaptopurine—ulcerative colitis	0.000753	0.00694	CcSEcCtD
Rilpivirine—ABCG2—Abacavir transport and metabolism—ABCB1—ulcerative colitis	0.000699	0.0219	CbGpPWpGaD
Rilpivirine—NR1I2—Nuclear Receptors—VDR—ulcerative colitis	0.000691	0.0216	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transport of organic anions—ALB—ulcerative colitis	0.000652	0.0204	CbGpPWpGaD
Rilpivirine—Immune system disorder—Mercaptopurine—ulcerative colitis	0.000646	0.00595	CcSEcCtD
Rilpivirine—Immune system disorder—Nicotine—ulcerative colitis	0.000626	0.00576	CcSEcCtD
Rilpivirine—Malnutrition—Mercaptopurine—ulcerative colitis	0.000622	0.00573	CcSEcCtD
Rilpivirine—Mental disorder—Nicotine—ulcerative colitis	0.000607	0.00559	CcSEcCtD
Rilpivirine—NR1I2—Generic Transcription Pathway—ZFP90—ulcerative colitis	0.00059	0.0185	CbGpPWpGaD
Rilpivirine—Renal impairment—Mesalazine—ulcerative colitis	0.000589	0.00543	CcSEcCtD
Rilpivirine—Inflammation—Hydrocortisone—ulcerative colitis	0.000566	0.00522	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptor transcription pathway—VDR—ulcerative colitis	0.000546	0.0171	CbGpPWpGaD
Rilpivirine—Inflammation—Methylprednisolone—ulcerative colitis	0.000532	0.0049	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000526	0.0165	CbGpPWpGaD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—ulcerative colitis	0.000526	0.00485	CcSEcCtD
Rilpivirine—Blood creatinine increased—Mesalazine—ulcerative colitis	0.000525	0.00484	CcSEcCtD
Rilpivirine—Anxiety—Nicotine—ulcerative colitis	0.000512	0.00471	CcSEcCtD
Rilpivirine—Abdominal discomfort—Azathioprine—ulcerative colitis	0.00051	0.0047	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Mesalazine—ulcerative colitis	0.000505	0.00465	CcSEcCtD
Rilpivirine—Dry mouth—Nicotine—ulcerative colitis	0.000502	0.00463	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Mesalazine—ulcerative colitis	0.000495	0.00456	CcSEcCtD
Rilpivirine—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000494	0.0155	CbGpPWpGaD
Rilpivirine—Skin disorder—Mercaptopurine—ulcerative colitis	0.000493	0.00454	CcSEcCtD
Rilpivirine—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000493	0.0154	CbGpPWpGaD
Rilpivirine—SLCO1B3—Recycling of bile acids and salts—ALB—ulcerative colitis	0.000483	0.0151	CbGpPWpGaD
Rilpivirine—Nervous system disorder—Nicotine—ulcerative colitis	0.000483	0.00445	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors—PPARG—ulcerative colitis	0.000482	0.0151	CbGpPWpGaD
Rilpivirine—Urinary tract disorder—Budesonide—ulcerative colitis	0.000471	0.00434	CcSEcCtD
Rilpivirine—Urethral disorder—Budesonide—ulcerative colitis	0.000468	0.00431	CcSEcCtD
Rilpivirine—Abdominal discomfort—Mesalazine—ulcerative colitis	0.000465	0.00428	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Azathioprine—ulcerative colitis	0.000449	0.00413	CcSEcCtD
Rilpivirine—Insomnia—Nicotine—ulcerative colitis	0.000445	0.0041	CcSEcCtD
Rilpivirine—Decreased appetite—Mercaptopurine—ulcerative colitis	0.000441	0.00407	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.000438	0.00404	CcSEcCtD
Rilpivirine—SLCO1B1—Transport of organic anions—ALB—ulcerative colitis	0.000438	0.0137	CbGpPWpGaD
Rilpivirine—Somnolence—Nicotine—ulcerative colitis	0.000437	0.00403	CcSEcCtD
Rilpivirine—Depression—Mesalazine—ulcerative colitis	0.000431	0.00397	CcSEcCtD
Rilpivirine—Immune system disorder—Budesonide—ulcerative colitis	0.000431	0.00397	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.000425	0.00391	CcSEcCtD
Rilpivirine—Renal failure—Mesalazine—ulcerative colitis	0.000425	0.00391	CcSEcCtD
Rilpivirine—Fatigue—Nicotine—ulcerative colitis	0.000424	0.00391	CcSEcCtD
Rilpivirine—Mental disorder—Budesonide—ulcerative colitis	0.000418	0.00385	CcSEcCtD
Rilpivirine—Malnutrition—Budesonide—ulcerative colitis	0.000415	0.00383	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Mesalazine—ulcerative colitis	0.000409	0.00377	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Nicotine—ulcerative colitis	0.000402	0.00371	CcSEcCtD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000393	0.0123	CbGpPWpGaD
Rilpivirine—Abdominal pain—Nicotine—ulcerative colitis	0.000389	0.00358	CcSEcCtD
Rilpivirine—Immune system disorder—Azathioprine—ulcerative colitis	0.000385	0.00354	CcSEcCtD
Rilpivirine—ABCB1—Allograft Rejection—MICA—ulcerative colitis	0.000384	0.012	CbGpPWpGaD
Rilpivirine—Urinary tract disorder—Mesalazine—ulcerative colitis	0.000383	0.00353	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptor transcription pathway—PPARG—ulcerative colitis	0.000381	0.0119	CbGpPWpGaD
Rilpivirine—Urethral disorder—Mesalazine—ulcerative colitis	0.00038	0.0035	CcSEcCtD
Rilpivirine—Asthenia—Nicotine—ulcerative colitis	0.000353	0.00325	CcSEcCtD
Rilpivirine—Anxiety—Budesonide—ulcerative colitis	0.000352	0.00325	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Hydrocortisone—ulcerative colitis	0.000352	0.00324	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000351	0.00323	CcSEcCtD
Rilpivirine—Immune system disorder—Mesalazine—ulcerative colitis	0.00035	0.00323	CcSEcCtD
Rilpivirine—Diarrhoea—Mercaptopurine—ulcerative colitis	0.000347	0.0032	CcSEcCtD
Rilpivirine—Dry mouth—Budesonide—ulcerative colitis	0.000346	0.00319	CcSEcCtD
Rilpivirine—Mental disorder—Mesalazine—ulcerative colitis	0.00034	0.00313	CcSEcCtD
Rilpivirine—Diarrhoea—Nicotine—ulcerative colitis	0.000337	0.0031	CcSEcCtD
Rilpivirine—Infection—Budesonide—ulcerative colitis	0.000337	0.0031	CcSEcCtD
Rilpivirine—Nervous system disorder—Budesonide—ulcerative colitis	0.000332	0.00306	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Methylprednisolone—ulcerative colitis	0.00033	0.00304	CcSEcCtD
Rilpivirine—Skin disorder—Budesonide—ulcerative colitis	0.000329	0.00303	CcSEcCtD
Rilpivirine—Dizziness—Nicotine—ulcerative colitis	0.000325	0.003	CcSEcCtD
Rilpivirine—SLCO1B1—Recycling of bile acids and salts—ALB—ulcerative colitis	0.000324	0.0102	CbGpPWpGaD
Rilpivirine—Vomiting—Mercaptopurine—ulcerative colitis	0.000323	0.00297	CcSEcCtD
Rilpivirine—Rash—Mercaptopurine—ulcerative colitis	0.00032	0.00295	CcSEcCtD
Rilpivirine—Dermatitis—Mercaptopurine—ulcerative colitis	0.00032	0.00295	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000313	0.00289	CcSEcCtD
Rilpivirine—Vomiting—Nicotine—ulcerative colitis	0.000313	0.00288	CcSEcCtD
Rilpivirine—Rash—Nicotine—ulcerative colitis	0.00031	0.00286	CcSEcCtD
Rilpivirine—Dermatitis—Nicotine—ulcerative colitis	0.00031	0.00286	CcSEcCtD
Rilpivirine—Headache—Nicotine—ulcerative colitis	0.000308	0.00284	CcSEcCtD
Rilpivirine—Insomnia—Budesonide—ulcerative colitis	0.000307	0.00282	CcSEcCtD
Rilpivirine—Nausea—Mercaptopurine—ulcerative colitis	0.000302	0.00278	CcSEcCtD
Rilpivirine—Somnolence—Budesonide—ulcerative colitis	0.000301	0.00278	CcSEcCtD
Rilpivirine—Infection—Azathioprine—ulcerative colitis	0.000301	0.00277	CcSEcCtD
Rilpivirine—Decreased appetite—Budesonide—ulcerative colitis	0.000295	0.00271	CcSEcCtD
Rilpivirine—Skin disorder—Azathioprine—ulcerative colitis	0.000294	0.00271	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000293	0.0027	CcSEcCtD
Rilpivirine—Nausea—Nicotine—ulcerative colitis	0.000292	0.00269	CcSEcCtD
Rilpivirine—Fatigue—Budesonide—ulcerative colitis	0.000292	0.00269	CcSEcCtD
Rilpivirine—Anxiety—Mesalazine—ulcerative colitis	0.000287	0.00264	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000286	0.00263	CcSEcCtD
Rilpivirine—NR1I2—Gene Expression—ZFP90—ulcerative colitis	0.000284	0.0089	CbGpPWpGaD
Rilpivirine—Dry mouth—Mesalazine—ulcerative colitis	0.000281	0.00259	CcSEcCtD
Rilpivirine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000278	0.00872	CbGpPWpGaD
Rilpivirine—Gastrointestinal pain—Budesonide—ulcerative colitis	0.000277	0.00255	CcSEcCtD
Rilpivirine—Infection—Mesalazine—ulcerative colitis	0.000274	0.00252	CcSEcCtD
Rilpivirine—NR1I2—Generic Transcription Pathway—NR5A2—ulcerative colitis	0.000271	0.00848	CbGpPWpGaD
Rilpivirine—Nervous system disorder—Mesalazine—ulcerative colitis	0.00027	0.00249	CcSEcCtD
Rilpivirine—Abdominal pain—Budesonide—ulcerative colitis	0.000268	0.00247	CcSEcCtD
Rilpivirine—Skin disorder—Mesalazine—ulcerative colitis	0.000268	0.00247	CcSEcCtD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000264	0.00826	CbGpPWpGaD
Rilpivirine—Alanine aminotransferase increased—Prednisone—ulcerative colitis	0.000262	0.00241	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000261	0.00241	CcSEcCtD
Rilpivirine—SLCO1B3—Bile acid and bile salt metabolism—ALB—ulcerative colitis	0.000252	0.0079	CbGpPWpGaD
Rilpivirine—Insomnia—Mesalazine—ulcerative colitis	0.000249	0.0023	CcSEcCtD
Rilpivirine—Immune system disorder—Hydrocortisone—ulcerative colitis	0.000249	0.0023	CcSEcCtD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	0.000248	0.00775	CbGpPWpGaD
Rilpivirine—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000247	0.00228	CcSEcCtD
Rilpivirine—ABCB1—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000247	0.00773	CbGpPWpGaD
Rilpivirine—Somnolence—Mesalazine—ulcerative colitis	0.000245	0.00226	CcSEcCtD
Rilpivirine—Asthenia—Budesonide—ulcerative colitis	0.000243	0.00224	CcSEcCtD
Rilpivirine—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—ulcerative colitis	0.000242	0.00757	CbGpPWpGaD
Rilpivirine—Mental disorder—Hydrocortisone—ulcerative colitis	0.000242	0.00223	CcSEcCtD
Rilpivirine—Malnutrition—Hydrocortisone—ulcerative colitis	0.00024	0.00221	CcSEcCtD
Rilpivirine—Decreased appetite—Mesalazine—ulcerative colitis	0.00024	0.00221	CcSEcCtD
Rilpivirine—Abdominal pain—Azathioprine—ulcerative colitis	0.000239	0.0022	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000238	0.00219	CcSEcCtD
Rilpivirine—Fatigue—Mesalazine—ulcerative colitis	0.000238	0.00219	CcSEcCtD
Rilpivirine—Immune system disorder—Methylprednisolone—ulcerative colitis	0.000234	0.00216	CcSEcCtD
Rilpivirine—Diarrhoea—Budesonide—ulcerative colitis	0.000232	0.00214	CcSEcCtD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000231	0.00725	CbGpPWpGaD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.000231	0.00725	CbGpPWpGaD
Rilpivirine—Depression—Prednisone—ulcerative colitis	0.000228	0.0021	CcSEcCtD
Rilpivirine—Mental disorder—Methylprednisolone—ulcerative colitis	0.000227	0.00209	CcSEcCtD
Rilpivirine—Malnutrition—Methylprednisolone—ulcerative colitis	0.000226	0.00208	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000225	0.00208	CcSEcCtD
Rilpivirine—Dizziness—Budesonide—ulcerative colitis	0.000224	0.00206	CcSEcCtD
Rilpivirine—Abdominal pain—Mesalazine—ulcerative colitis	0.000218	0.00201	CcSEcCtD
Rilpivirine—Vomiting—Budesonide—ulcerative colitis	0.000215	0.00199	CcSEcCtD
Rilpivirine—Rash—Budesonide—ulcerative colitis	0.000214	0.00197	CcSEcCtD
Rilpivirine—Dermatitis—Budesonide—ulcerative colitis	0.000213	0.00197	CcSEcCtD
Rilpivirine—Headache—Budesonide—ulcerative colitis	0.000212	0.00196	CcSEcCtD
Rilpivirine—Diarrhoea—Azathioprine—ulcerative colitis	0.000207	0.00191	CcSEcCtD
Rilpivirine—Anxiety—Hydrocortisone—ulcerative colitis	0.000204	0.00188	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000203	0.00187	CcSEcCtD
Rilpivirine—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000202	0.00633	CbGpPWpGaD
Rilpivirine—Nausea—Budesonide—ulcerative colitis	0.000201	0.00185	CcSEcCtD
Rilpivirine—Dizziness—Azathioprine—ulcerative colitis	0.0002	0.00184	CcSEcCtD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.0002	0.00625	CbGpPWpGaD
Rilpivirine—Asthenia—Mesalazine—ulcerative colitis	0.000198	0.00182	CcSEcCtD
Rilpivirine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—ulcerative colitis	0.000196	0.00614	CbGpPWpGaD
Rilpivirine—Infection—Hydrocortisone—ulcerative colitis	0.000195	0.00179	CcSEcCtD
Rilpivirine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000193	0.00603	CbGpPWpGaD
Rilpivirine—Vomiting—Azathioprine—ulcerative colitis	0.000192	0.00177	CcSEcCtD
Rilpivirine—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000192	0.00177	CcSEcCtD
Rilpivirine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000192	0.00602	CbGpPWpGaD
Rilpivirine—Anxiety—Methylprednisolone—ulcerative colitis	0.000191	0.00176	CcSEcCtD
Rilpivirine—Rash—Azathioprine—ulcerative colitis	0.000191	0.00176	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000191	0.00176	CcSEcCtD
Rilpivirine—Dermatitis—Azathioprine—ulcerative colitis	0.000191	0.00176	CcSEcCtD
Rilpivirine—Skin disorder—Hydrocortisone—ulcerative colitis	0.00019	0.00175	CcSEcCtD
Rilpivirine—Headache—Azathioprine—ulcerative colitis	0.00019	0.00175	CcSEcCtD
Rilpivirine—Diarrhoea—Mesalazine—ulcerative colitis	0.000189	0.00174	CcSEcCtD
Rilpivirine—Dry mouth—Triamcinolone—ulcerative colitis	0.000188	0.00173	CcSEcCtD
Rilpivirine—Immune system disorder—Prednisone—ulcerative colitis	0.000185	0.00171	CcSEcCtD
Rilpivirine—Infection—Triamcinolone—ulcerative colitis	0.000183	0.00169	CcSEcCtD
Rilpivirine—Infection—Methylprednisolone—ulcerative colitis	0.000183	0.00169	CcSEcCtD
Rilpivirine—Dizziness—Mesalazine—ulcerative colitis	0.000182	0.00168	CcSEcCtD
Rilpivirine—Insomnia—Prednisolone—ulcerative colitis	0.000181	0.00167	CcSEcCtD
Rilpivirine—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000181	0.00166	CcSEcCtD
Rilpivirine—Mental disorder—Prednisone—ulcerative colitis	0.00018	0.00166	CcSEcCtD
Rilpivirine—Nausea—Azathioprine—ulcerative colitis	0.00018	0.00166	CcSEcCtD
Rilpivirine—Skin disorder—Methylprednisolone—ulcerative colitis	0.000179	0.00165	CcSEcCtD
Rilpivirine—Malnutrition—Prednisone—ulcerative colitis	0.000179	0.00165	CcSEcCtD
Rilpivirine—Insomnia—Hydrocortisone—ulcerative colitis	0.000177	0.00163	CcSEcCtD
Rilpivirine—Vomiting—Mesalazine—ulcerative colitis	0.000175	0.00161	CcSEcCtD
Rilpivirine—Anxiety—Dexamethasone—ulcerative colitis	0.000174	0.0016	CcSEcCtD
Rilpivirine—Anxiety—Betamethasone—ulcerative colitis	0.000174	0.0016	CcSEcCtD
Rilpivirine—Rash—Mesalazine—ulcerative colitis	0.000174	0.0016	CcSEcCtD
Rilpivirine—Dermatitis—Mesalazine—ulcerative colitis	0.000174	0.0016	CcSEcCtD
Rilpivirine—Headache—Mesalazine—ulcerative colitis	0.000173	0.00159	CcSEcCtD
Rilpivirine—Decreased appetite—Hydrocortisone—ulcerative colitis	0.00017	0.00157	CcSEcCtD
Rilpivirine—SLCO1B1—Bile acid and bile salt metabolism—ALB—ulcerative colitis	0.00017	0.00531	CbGpPWpGaD
Rilpivirine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000169	0.00156	CcSEcCtD
Rilpivirine—Fatigue—Hydrocortisone—ulcerative colitis	0.000169	0.00156	CcSEcCtD
Rilpivirine—Insomnia—Triamcinolone—ulcerative colitis	0.000167	0.00154	CcSEcCtD
Rilpivirine—Insomnia—Methylprednisolone—ulcerative colitis	0.000167	0.00153	CcSEcCtD
Rilpivirine—Infection—Dexamethasone—ulcerative colitis	0.000166	0.00153	CcSEcCtD
Rilpivirine—Infection—Betamethasone—ulcerative colitis	0.000166	0.00153	CcSEcCtD
Rilpivirine—Nervous system disorder—Betamethasone—ulcerative colitis	0.000164	0.00151	CcSEcCtD
Rilpivirine—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000164	0.00151	CcSEcCtD
Rilpivirine—Nausea—Mesalazine—ulcerative colitis	0.000164	0.00151	CcSEcCtD
Rilpivirine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—ulcerative colitis	0.000162	0.00508	CbGpPWpGaD
Rilpivirine—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.00016	0.00148	CcSEcCtD
Rilpivirine—Fatigue—Triamcinolone—ulcerative colitis	0.000159	0.00147	CcSEcCtD
Rilpivirine—Fatigue—Methylprednisolone—ulcerative colitis	0.000159	0.00146	CcSEcCtD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000155	0.00487	CbGpPWpGaD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.000155	0.00487	CbGpPWpGaD
Rilpivirine—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000155	0.00143	CcSEcCtD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—ABCB1—ulcerative colitis	0.000155	0.00484	CbGpPWpGaD
Rilpivirine—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000153	0.00478	CbGpPWpGaD
Rilpivirine—CYP2C19—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000153	0.00478	CbGpPWpGaD
Rilpivirine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000152	0.00477	CbGpPWpGaD
Rilpivirine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000152	0.00476	CbGpPWpGaD
Rilpivirine—Anxiety—Prednisone—ulcerative colitis	0.000152	0.0014	CcSEcCtD
Rilpivirine—Insomnia—Betamethasone—ulcerative colitis	0.000151	0.0014	CcSEcCtD
Rilpivirine—Insomnia—Dexamethasone—ulcerative colitis	0.000151	0.0014	CcSEcCtD
Rilpivirine—NR1I2—Generic Transcription Pathway—HNF4A—ulcerative colitis	0.000151	0.00474	CbGpPWpGaD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000151	0.00139	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000151	0.00139	CcSEcCtD
Rilpivirine—NR1I2—Generic Transcription Pathway—MAML2—ulcerative colitis	0.000148	0.00462	CbGpPWpGaD
Rilpivirine—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000146	0.00134	CcSEcCtD
Rilpivirine—Decreased appetite—Dexamethasone—ulcerative colitis	0.000146	0.00134	CcSEcCtD
Rilpivirine—Decreased appetite—Betamethasone—ulcerative colitis	0.000146	0.00134	CcSEcCtD
Rilpivirine—Infection—Prednisone—ulcerative colitis	0.000145	0.00133	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000145	0.00133	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000145	0.00133	CcSEcCtD
Rilpivirine—Fatigue—Dexamethasone—ulcerative colitis	0.000144	0.00133	CcSEcCtD
Rilpivirine—Fatigue—Betamethasone—ulcerative colitis	0.000144	0.00133	CcSEcCtD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000144	0.00451	CbGpPWpGaD
Rilpivirine—Nervous system disorder—Prednisone—ulcerative colitis	0.000143	0.00132	CcSEcCtD
Rilpivirine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000142	0.00444	CbGpPWpGaD
Rilpivirine—Skin disorder—Prednisone—ulcerative colitis	0.000142	0.0013	CcSEcCtD
Rilpivirine—CYP2B6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000142	0.00443	CbGpPWpGaD
Rilpivirine—Asthenia—Hydrocortisone—ulcerative colitis	0.000141	0.0013	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000137	0.00126	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000137	0.00126	CcSEcCtD
Rilpivirine—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000134	0.00124	CcSEcCtD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000134	0.0042	CbGpPWpGaD
Rilpivirine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000134	0.0042	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	0.000134	0.00419	CbGpPWpGaD
Rilpivirine—Dizziness—Prednisolone—ulcerative colitis	0.000133	0.00122	CcSEcCtD
Rilpivirine—Asthenia—Triamcinolone—ulcerative colitis	0.000132	0.00122	CcSEcCtD
Rilpivirine—Abdominal pain—Betamethasone—ulcerative colitis	0.000132	0.00122	CcSEcCtD
Rilpivirine—Abdominal pain—Dexamethasone—ulcerative colitis	0.000132	0.00122	CcSEcCtD
Rilpivirine—Asthenia—Methylprednisolone—ulcerative colitis	0.000132	0.00122	CcSEcCtD
Rilpivirine—Insomnia—Prednisone—ulcerative colitis	0.000132	0.00122	CcSEcCtD
Rilpivirine—NR1I2—Gene Expression—NR5A2—ulcerative colitis	0.00013	0.00408	CbGpPWpGaD
Rilpivirine—Dizziness—Hydrocortisone—ulcerative colitis	0.00013	0.00119	CcSEcCtD
Rilpivirine—Decreased appetite—Prednisone—ulcerative colitis	0.000127	0.00117	CcSEcCtD
Rilpivirine—Rash—Prednisolone—ulcerative colitis	0.000127	0.00117	CcSEcCtD
Rilpivirine—Dermatitis—Prednisolone—ulcerative colitis	0.000126	0.00116	CcSEcCtD
Rilpivirine—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000126	0.00116	CcSEcCtD
Rilpivirine—Fatigue—Prednisone—ulcerative colitis	0.000126	0.00116	CcSEcCtD
Rilpivirine—Headache—Prednisolone—ulcerative colitis	0.000126	0.00116	CcSEcCtD
Rilpivirine—Vomiting—Hydrocortisone—ulcerative colitis	0.000125	0.00115	CcSEcCtD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000124	0.00389	CbGpPWpGaD
Rilpivirine—Rash—Hydrocortisone—ulcerative colitis	0.000124	0.00114	CcSEcCtD
Rilpivirine—Dermatitis—Hydrocortisone—ulcerative colitis	0.000123	0.00114	CcSEcCtD
Rilpivirine—Headache—Hydrocortisone—ulcerative colitis	0.000123	0.00113	CcSEcCtD
Rilpivirine—Dizziness—Triamcinolone—ulcerative colitis	0.000122	0.00112	CcSEcCtD
Rilpivirine—Dizziness—Methylprednisolone—ulcerative colitis	0.000122	0.00112	CcSEcCtD
Rilpivirine—Asthenia—Betamethasone—ulcerative colitis	0.00012	0.00111	CcSEcCtD
Rilpivirine—Asthenia—Dexamethasone—ulcerative colitis	0.00012	0.00111	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000119	0.0011	CcSEcCtD
Rilpivirine—Nausea—Prednisolone—ulcerative colitis	0.000119	0.0011	CcSEcCtD
Rilpivirine—CYP1A2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000119	0.00372	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.000118	0.0037	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000118	0.00368	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000118	0.00368	CbGpPWpGaD
Rilpivirine—Vomiting—Triamcinolone—ulcerative colitis	0.000117	0.00108	CcSEcCtD
Rilpivirine—Vomiting—Methylprednisolone—ulcerative colitis	0.000117	0.00108	CcSEcCtD
Rilpivirine—Nausea—Hydrocortisone—ulcerative colitis	0.000116	0.00107	CcSEcCtD
Rilpivirine—Rash—Triamcinolone—ulcerative colitis	0.000116	0.00107	CcSEcCtD
Rilpivirine—Dermatitis—Triamcinolone—ulcerative colitis	0.000116	0.00107	CcSEcCtD
Rilpivirine—Rash—Methylprednisolone—ulcerative colitis	0.000116	0.00107	CcSEcCtD
Rilpivirine—Dermatitis—Methylprednisolone—ulcerative colitis	0.000116	0.00107	CcSEcCtD
Rilpivirine—Headache—Triamcinolone—ulcerative colitis	0.000116	0.00107	CcSEcCtD
Rilpivirine—Headache—Methylprednisolone—ulcerative colitis	0.000115	0.00106	CcSEcCtD
Rilpivirine—Abdominal pain—Prednisone—ulcerative colitis	0.000115	0.00106	CcSEcCtD
Rilpivirine—Diarrhoea—Betamethasone—ulcerative colitis	0.000115	0.00106	CcSEcCtD
Rilpivirine—Diarrhoea—Dexamethasone—ulcerative colitis	0.000115	0.00106	CcSEcCtD
Rilpivirine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000113	0.00355	CbGpPWpGaD
Rilpivirine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000113	0.00354	CbGpPWpGaD
Rilpivirine—Dizziness—Dexamethasone—ulcerative colitis	0.000111	0.00102	CcSEcCtD
Rilpivirine—Dizziness—Betamethasone—ulcerative colitis	0.000111	0.00102	CcSEcCtD
Rilpivirine—Nausea—Triamcinolone—ulcerative colitis	0.00011	0.00101	CcSEcCtD
Rilpivirine—Nausea—Methylprednisolone—ulcerative colitis	0.000109	0.00101	CcSEcCtD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000109	0.00341	CbGpPWpGaD
Rilpivirine—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000107	0.00335	CbGpPWpGaD
Rilpivirine—Vomiting—Dexamethasone—ulcerative colitis	0.000106	0.000981	CcSEcCtD
Rilpivirine—Vomiting—Betamethasone—ulcerative colitis	0.000106	0.000981	CcSEcCtD
Rilpivirine—Rash—Betamethasone—ulcerative colitis	0.000106	0.000973	CcSEcCtD
Rilpivirine—Rash—Dexamethasone—ulcerative colitis	0.000106	0.000973	CcSEcCtD
Rilpivirine—Dermatitis—Dexamethasone—ulcerative colitis	0.000105	0.000972	CcSEcCtD
Rilpivirine—Dermatitis—Betamethasone—ulcerative colitis	0.000105	0.000972	CcSEcCtD
Rilpivirine—Headache—Dexamethasone—ulcerative colitis	0.000105	0.000966	CcSEcCtD
Rilpivirine—Headache—Betamethasone—ulcerative colitis	0.000105	0.000966	CcSEcCtD
Rilpivirine—Asthenia—Prednisone—ulcerative colitis	0.000105	0.000964	CcSEcCtD
Rilpivirine—CYP1A2—Estrogen Receptor Pathway—STAT3—ulcerative colitis	0.000104	0.00327	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	0.000103	0.00324	CbGpPWpGaD
Rilpivirine—Diarrhoea—Prednisone—ulcerative colitis	9.98e-05	0.000919	CcSEcCtD
Rilpivirine—Nausea—Dexamethasone—ulcerative colitis	9.95e-05	0.000916	CcSEcCtD
Rilpivirine—Nausea—Betamethasone—ulcerative colitis	9.95e-05	0.000916	CcSEcCtD
Rilpivirine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	9.88e-05	0.00309	CbGpPWpGaD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	9.68e-05	0.00303	CbGpPWpGaD
Rilpivirine—Dizziness—Prednisone—ulcerative colitis	9.64e-05	0.000888	CcSEcCtD
Rilpivirine—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	9.61e-05	0.00301	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—VDR—ulcerative colitis	9.43e-05	0.00295	CbGpPWpGaD
Rilpivirine—Vomiting—Prednisone—ulcerative colitis	9.27e-05	0.000854	CcSEcCtD
Rilpivirine—Rash—Prednisone—ulcerative colitis	9.19e-05	0.000847	CcSEcCtD
Rilpivirine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	9.19e-05	0.00288	CbGpPWpGaD
Rilpivirine—Dermatitis—Prednisone—ulcerative colitis	9.19e-05	0.000846	CcSEcCtD
Rilpivirine—Headache—Prednisone—ulcerative colitis	9.13e-05	0.000842	CcSEcCtD
Rilpivirine—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	9.03e-05	0.00283	CbGpPWpGaD
Rilpivirine—ABCG2—Fluoropyrimidine Activity—TP53—ulcerative colitis	8.76e-05	0.00274	CbGpPWpGaD
Rilpivirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	8.75e-05	0.00274	CbGpPWpGaD
Rilpivirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	8.73e-05	0.00273	CbGpPWpGaD
Rilpivirine—Nausea—Prednisone—ulcerative colitis	8.66e-05	0.000798	CcSEcCtD
Rilpivirine—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	8.33e-05	0.00261	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	7.95e-05	0.00249	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	7.9e-05	0.00247	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	7.9e-05	0.00247	CbGpPWpGaD
Rilpivirine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	7.89e-05	0.00247	CbGpPWpGaD
Rilpivirine—CYP2C19—Melatonin metabolism and effects—NFKB1—ulcerative colitis	7.85e-05	0.00246	CbGpPWpGaD
Rilpivirine—CYP2B6—Biological oxidations—PTGS1—ulcerative colitis	7.52e-05	0.00235	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	7.32e-05	0.00229	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	7.32e-05	0.00229	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	7.32e-05	0.00229	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—HNF4A—ulcerative colitis	7.29e-05	0.00228	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—MAML2—ulcerative colitis	7.1e-05	0.00222	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL10—ulcerative colitis	7.02e-05	0.0022	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CHP1—ulcerative colitis	6.76e-05	0.00212	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	6.71e-05	0.0021	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—PPARG—ulcerative colitis	6.57e-05	0.00206	CbGpPWpGaD
Rilpivirine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	6.43e-05	0.00201	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	6.33e-05	0.00198	CbGpPWpGaD
Rilpivirine—CYP1A2—Melatonin metabolism and effects—NFKB1—ulcerative colitis	6.12e-05	0.00192	CbGpPWpGaD
Rilpivirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	6.09e-05	0.00191	CbGpPWpGaD
Rilpivirine—CYP2C19—Arachidonic acid metabolism—PTGS2—ulcerative colitis	5.85e-05	0.00183	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—DLD—ulcerative colitis	5.83e-05	0.00183	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	5.72e-05	0.00179	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—PTGS1—ulcerative colitis	5.68e-05	0.00178	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	5.66e-05	0.00177	CbGpPWpGaD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—ALB—ulcerative colitis	5.19e-05	0.00162	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	5.08e-05	0.00159	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	5.01e-05	0.00157	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	4.92e-05	0.00154	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	4.87e-05	0.00153	CbGpPWpGaD
Rilpivirine—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	4.56e-05	0.00143	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	4.56e-05	0.00143	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—VDR—ulcerative colitis	4.54e-05	0.00142	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CHP1—ulcerative colitis	4.54e-05	0.00142	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	4.53e-05	0.00142	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	4.52e-05	0.00141	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	4.43e-05	0.00139	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	4.25e-05	0.00133	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	4.23e-05	0.00132	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	4.22e-05	0.00132	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CHP1—ulcerative colitis	4.2e-05	0.00132	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	4.13e-05	0.00129	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	3.96e-05	0.00124	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	3.96e-05	0.00124	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	3.93e-05	0.00123	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—DLD—ulcerative colitis	3.92e-05	0.00123	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	3.84e-05	0.0012	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	3.68e-05	0.00115	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL2—ulcerative colitis	3.67e-05	0.00115	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—DLD—ulcerative colitis	3.63e-05	0.00114	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	3.52e-05	0.0011	CbGpPWpGaD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—ALB—ulcerative colitis	3.49e-05	0.00109	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	3.42e-05	0.00107	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	3.29e-05	0.00103	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	3.29e-05	0.00103	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—PPARG—ulcerative colitis	3.16e-05	0.000991	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.08e-05	0.000966	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CHP1—ulcerative colitis	3.08e-05	0.000965	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	2.86e-05	0.000897	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	2.83e-05	0.000887	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTGS1—ulcerative colitis	2.82e-05	0.000883	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.77e-05	0.000868	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—TNF—ulcerative colitis	2.67e-05	0.000837	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—DLD—ulcerative colitis	2.66e-05	0.000833	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.64e-05	0.000827	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.64e-05	0.000826	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	2.62e-05	0.000821	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CALM3—ulcerative colitis	2.54e-05	0.000795	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.46e-05	0.000771	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.45e-05	0.000766	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.43e-05	0.00076	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CHP1—ulcerative colitis	2.33e-05	0.000729	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CHP1—ulcerative colitis	2.27e-05	0.000712	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.18e-05	0.000683	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.07e-05	0.000649	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—DLD—ulcerative colitis	2.01e-05	0.000629	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—ABCB1—ulcerative colitis	1.97e-05	0.000618	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—DLD—ulcerative colitis	1.96e-05	0.000614	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.95e-05	0.000612	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTGS1—ulcerative colitis	1.89e-05	0.000593	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.86e-05	0.000583	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—ADCY5—ulcerative colitis	1.84e-05	0.000577	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CHP1—ulcerative colitis	1.81e-05	0.000568	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.77e-05	0.000555	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTGS1—ulcerative colitis	1.75e-05	0.000549	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CALM3—ulcerative colitis	1.71e-05	0.000534	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.7e-05	0.000532	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.7e-05	0.000531	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.64e-05	0.000514	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.63e-05	0.00051	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CALM3—ulcerative colitis	1.58e-05	0.000495	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—DLD—ulcerative colitis	1.57e-05	0.00049	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.41e-05	0.000442	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.4e-05	0.000438	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PPARG—ulcerative colitis	1.37e-05	0.00043	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ABCB1—ulcerative colitis	1.33e-05	0.000415	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.32e-05	0.000414	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.32e-05	0.000413	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTGS1—ulcerative colitis	1.29e-05	0.000403	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ADCY5—ulcerative colitis	1.24e-05	0.000387	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—ALB—ulcerative colitis	1.24e-05	0.000387	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ABCB1—ulcerative colitis	1.23e-05	0.000385	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—DLD—ulcerative colitis	1.21e-05	0.000378	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.16e-05	0.000364	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CALM3—ulcerative colitis	1.16e-05	0.000363	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ADCY5—ulcerative colitis	1.15e-05	0.000359	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTGS2—ulcerative colitis	1.08e-05	0.000338	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.06e-05	0.000333	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTGS1—ulcerative colitis	9.72e-06	0.000304	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	9.56e-06	0.000299	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTGS1—ulcerative colitis	9.48e-06	0.000297	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PPARG—ulcerative colitis	9.23e-06	0.000289	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ABCB1—ulcerative colitis	9e-06	0.000282	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	8.87e-06	0.000278	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CALM3—ulcerative colitis	8.75e-06	0.000274	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PPARG—ulcerative colitis	8.54e-06	0.000268	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CALM3—ulcerative colitis	8.54e-06	0.000267	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ADCY5—ulcerative colitis	8.4e-06	0.000263	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	8.36e-06	0.000262	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ALB—ulcerative colitis	8.3e-06	0.00026	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.28e-06	0.000259	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ALB—ulcerative colitis	7.68e-06	0.000241	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTGS1—ulcerative colitis	7.57e-06	0.000237	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.45e-06	0.000233	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTGS2—ulcerative colitis	7.26e-06	0.000227	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CALM3—ulcerative colitis	6.82e-06	0.000213	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ABCB1—ulcerative colitis	6.8e-06	0.000213	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTGS2—ulcerative colitis	6.72e-06	0.00021	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.51e-06	0.000204	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ADCY5—ulcerative colitis	6.35e-06	0.000199	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PPARG—ulcerative colitis	6.26e-06	0.000196	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ADCY5—ulcerative colitis	6.19e-06	0.000194	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTGS1—ulcerative colitis	5.84e-06	0.000183	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ALB—ulcerative colitis	5.63e-06	0.000176	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ABCB1—ulcerative colitis	5.3e-06	0.000166	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CALM3—ulcerative colitis	5.26e-06	0.000165	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ADCY5—ulcerative colitis	4.95e-06	0.000155	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTGS2—ulcerative colitis	4.93e-06	0.000154	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PPARG—ulcerative colitis	4.73e-06	0.000148	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PPARG—ulcerative colitis	4.62e-06	0.000145	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ALB—ulcerative colitis	4.26e-06	0.000133	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ALB—ulcerative colitis	4.15e-06	0.00013	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ABCB1—ulcerative colitis	4.09e-06	0.000128	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ADCY5—ulcerative colitis	3.82e-06	0.00012	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTGS2—ulcerative colitis	3.72e-06	0.000117	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PPARG—ulcerative colitis	3.69e-06	0.000115	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTGS2—ulcerative colitis	3.63e-06	0.000114	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ALB—ulcerative colitis	3.32e-06	0.000104	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTGS2—ulcerative colitis	2.9e-06	9.08e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PPARG—ulcerative colitis	2.85e-06	8.91e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ALB—ulcerative colitis	2.56e-06	8.01e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTGS2—ulcerative colitis	2.24e-06	7.01e-05	CbGpPWpGaD
